Kai Wang, MD, PhD
Kai Wang, MD, PhD
Bioinformatics Scientist
Foundation Medicine, Inc.
150 Second Street
Cambridge,
MA
USA
02140
Papers:
152
Comprehensive genomic profiling of advanced stage endometrioid endometrial adenocarcinomas (EEAC) reveals differences associated with CTNNB1 mutation status and a high frequency of clinically relevant genomic alterations